Ya-Chen Lin

5PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyPharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2024
IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma.

Shreya Badhrinarayanan, Christopher Cotter, Huaqi Zhu

|Mar 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Joel Neal, Nick Pavlakis, Sang-We Kim

|Oct 18, 2023
Accentuated Paralimbic and Reduced Mesolimbic D2/3-Impulsivity Associations in Parkinson's Disease.

Adam J Stark, Alexander K Song, Kalen J Petersen

|Apr 29, 2021
Symptoms of Medication Withdrawal in Parkinson's Disease: Considerations for Informed Consent in Patient-Oriented Research.

Kaitlyn R Hay, Neevi Kukreti, Paula Trujillo

|Feb 28, 2018
Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.

Adam J Stark, Christopher T Smith, Ya-Chen Lin

Pageof 1

Frequent Collaborators

3 joint publications

Hakmook Kang

3 joint publications

Daniel O Claassen

2 joint publications

Paula Trujillo

1 joint publications

Kalen J Petersen